Home
About
FAQ
History (9)
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
Waterman, Brian
Can the risk of non-home discharge after resection of gastric adenocarcinoma be predicted: a seven-institution study of the US Gastric Cancer Collaborative.
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol. 2014 Oct; 110(5):575-84.
View in:
PubMed
subject areas
Abdominal Neoplasms
Antineoplastic Combined Chemotherapy Protocols
Colorectal Neoplasms
Combined Modality Therapy
Female
Humans
Hyperthermia, Induced
Peritoneal Neoplasms
Treatment Outcome
authors with profiles
Edward A. Levine MD
Perry Shen MD
Konstantinos Votanopoulos MD, PhD, FACS